Mandate

Vinge advises Active Biotech in relation to directed new share issue

April 04, 2013

In March this year, Active Biotech AB (publ) conducted a directed new share issue to Investor AB (publ) pursuant to which Active Biotech procured SEK 270 million.

Vinge’s team consisted of partner Erik Sjöman and associate Christian Lindhé.

Related

Vinge advises Got Your Back on its acquisition of Nordic Depository Services' operations within depositary services for alternative investment funds

Nordic Depositary Services provides depositary services for alternative investment funds with focus on real estate and renewable energies.
September 10, 2024

Vinge advises the sellers in conjunction with the sale of Keeros AB

Keeros AB is a fintech company that offers comprehensive solutions for invoicing, lending and leasing. The acquisition was made by Marathon Software AB which is an investment company niched towards software companies.
September 10, 2024

Vinge advises the sellers in conjunction with the sale of Konsert Strategy & IP AB

Konsert Strategy & IP AB, is a Swedish management consultancy company blending business strategy and intellectual property. The acquisition was made by Rouse International, a leading international firm offering intellectual property services.
September 10, 2024